Listed

ICU Medical Inc

ICUINasdaqCIK 883984HealthcareFiscal year ends Dec 31

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$551.7m, Q2 FY2026
Operating income$39.1m, Q2 FY2026
Net income$19.1m, Q2 FY2026
ICU Medical Inc, income statement, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$m553Revenue, Q3 FY2023, three months to 2023-09-30$553.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2024-11-12, accession 0000883984-24-000042.Report this figure588Revenue, Q4 FY2023, three months to 2023-12-31$587.9m. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-19, accession 0000883984-26-000008. Derived: 12-month figure less the 9-month figure.Report this figure567Revenue, Q1 FY2024, three months to 2024-03-31$566.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-05-08, accession 0000883984-25-000016.Report this figure596Revenue, Q2 FY2024, three months to 2024-06-30$596.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-08-07, accession 0000883984-25-000030.Report this figure589Revenue, Q3 FY2024, three months to 2024-09-30$589.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-06, accession 0000883984-25-000035.Report this figure630Revenue, Q4 FY2024, three months to 2024-12-31$629.8m. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-19, accession 0000883984-26-000008. Derived: 12-month figure less the 9-month figure.Report this figure605Revenue, Q1 FY2025, three months to 2025-03-31$604.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-07, accession 0000883984-26-000029.Report this figure549Revenue, Q2 FY2025, three months to 2025-06-30$548.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-06, accession 0000883984-26-000041.Report this figure537Revenue, Q3 FY2025, three months to 2025-09-30$537.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-06, accession 0000883984-25-000035.Report this figure541Revenue, Q4 FY2025, three months to 2025-12-31$540.7m. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-19, accession 0000883984-26-000008. Derived: 12-month figure less the 9-month figure.Report this figure530Revenue, Q1 FY2026, three months to 2026-03-31$530.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-07, accession 0000883984-26-000029.Report this figure552Revenue, Q2 FY2026, three months to 2026-06-30$551.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-06, accession 0000883984-26-000041.Report this figure
Cost of revenue$m369Cost of revenue, Q3 FY2023, three months to 2023-09-30$369.4m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2024-11-12, accession 0000883984-24-000042.Report this figure416Cost of revenue, Q4 FY2023, three months to 2023-12-31$416.3m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2026-02-19, accession 0000883984-26-000008. Derived: 12-month figure less the 9-month figure.Report this figure381Cost of revenue, Q1 FY2024, three months to 2024-03-31$381.4m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2025-05-08, accession 0000883984-25-000016.Report this figure389Cost of revenue, Q2 FY2024, three months to 2024-06-30$389.0m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2025-08-07, accession 0000883984-25-000030.Report this figure384Cost of revenue, Q3 FY2024, three months to 2024-09-30$384.3m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2025-11-06, accession 0000883984-25-000035.Report this figure403Cost of revenue, Q4 FY2024, three months to 2024-12-31$402.5m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2026-02-19, accession 0000883984-26-000008. Derived: 12-month figure less the 9-month figure.Report this figure395Cost of revenue, Q1 FY2025, three months to 2025-03-31$394.6m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2026-05-07, accession 0000883984-26-000029.Report this figure341Cost of revenue, Q2 FY2025, three months to 2025-06-30$340.8m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2026-08-06, accession 0000883984-26-000041.Report this figure336Cost of revenue, Q3 FY2025, three months to 2025-09-30$336.1m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2025-11-06, accession 0000883984-25-000035.Report this figure338Cost of revenue, Q4 FY2025, three months to 2025-12-31$337.7m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2026-02-19, accession 0000883984-26-000008. Derived: 12-month figure less the 9-month figure.Report this figure324Cost of revenue, Q1 FY2026, three months to 2026-03-31$324.0m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2026-05-07, accession 0000883984-26-000029.Report this figure317Cost of revenue, Q2 FY2026, three months to 2026-06-30$316.6m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2026-08-06, accession 0000883984-26-000041.Report this figure
Gross profit$m184Gross profit, Q3 FY2023, three months to 2023-09-30$183.9m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2024-11-12, accession 0000883984-24-000042.Report this figure172Gross profit, Q4 FY2023, three months to 2023-12-31$171.6m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-02-19, accession 0000883984-26-000008. Derived: 12-month figure less the 9-month figure.Report this figure185Gross profit, Q1 FY2024, three months to 2024-03-31$185.2m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-05-08, accession 0000883984-25-000016.Report this figure207Gross profit, Q2 FY2024, three months to 2024-06-30$207.4m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-08-07, accession 0000883984-25-000030.Report this figure205Gross profit, Q3 FY2024, three months to 2024-09-30$204.9m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-11-06, accession 0000883984-25-000035.Report this figure227Gross profit, Q4 FY2024, three months to 2024-12-31$227.3m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-02-19, accession 0000883984-26-000008. Derived: 12-month figure less the 9-month figure.Report this figure210Gross profit, Q1 FY2025, three months to 2025-03-31$210.1m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-05-07, accession 0000883984-26-000029.Report this figure208Gross profit, Q2 FY2025, three months to 2025-06-30$208.1m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-06, accession 0000883984-26-000041.Report this figure201Gross profit, Q3 FY2025, three months to 2025-09-30$200.9m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-11-06, accession 0000883984-25-000035.Report this figure203Gross profit, Q4 FY2025, three months to 2025-12-31$203.0m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-02-19, accession 0000883984-26-000008. Derived: 12-month figure less the 9-month figure.Report this figure206Gross profit, Q1 FY2026, three months to 2026-03-31$206.2m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-05-07, accession 0000883984-26-000029.Report this figure235Gross profit, Q2 FY2026, three months to 2026-06-30$235.1m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-06, accession 0000883984-26-000041.Report this figure
Research and development$m20.9Research and development, Q3 FY2023, three months to 2023-09-30$20.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-12, accession 0000883984-24-000042.Report this figure22.4Research and development, Q4 FY2023, three months to 2023-12-31$22.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-02-19, accession 0000883984-26-000008. Derived: 12-month figure less the 9-month figure.Report this figure21.8Research and development, Q1 FY2024, three months to 2024-03-31$21.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-08, accession 0000883984-25-000016.Report this figure23.4Research and development, Q2 FY2024, three months to 2024-06-30$23.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-07, accession 0000883984-25-000030.Report this figure21.0Research and development, Q3 FY2024, three months to 2024-09-30$21.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-06, accession 0000883984-25-000035.Report this figure22.4Research and development, Q4 FY2024, three months to 2024-12-31$22.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-02-19, accession 0000883984-26-000008. Derived: 12-month figure less the 9-month figure.Report this figure23.3Research and development, Q1 FY2025, three months to 2025-03-31$23.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-07, accession 0000883984-26-000029.Report this figure21.9Research and development, Q2 FY2025, three months to 2025-06-30$21.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-06, accession 0000883984-26-000041.Report this figure21.3Research and development, Q3 FY2025, three months to 2025-09-30$21.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-06, accession 0000883984-25-000035.Report this figure21.1Research and development, Q4 FY2025, three months to 2025-12-31$21.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-02-19, accession 0000883984-26-000008. Derived: 12-month figure less the 9-month figure.Report this figure21.3Research and development, Q1 FY2026, three months to 2026-03-31$21.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-07, accession 0000883984-26-000029.Report this figure22.7Research and development, Q2 FY2026, three months to 2026-06-30$22.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-06, accession 0000883984-26-000041.Report this figure
Selling, general and administrative$m149Selling, general and administrative, Q3 FY2023, three months to 2023-09-30$148.6m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2024-11-12, accession 0000883984-24-000042.Report this figure155Selling, general and administrative, Q4 FY2023, three months to 2023-12-31$154.6m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-02-19, accession 0000883984-26-000008. Derived: 12-month figure less the 9-month figure.Report this figure158Selling, general and administrative, Q1 FY2024, three months to 2024-03-31$157.7m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-05-08, accession 0000883984-25-000016.Report this figure160Selling, general and administrative, Q2 FY2024, three months to 2024-06-30$159.5m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-08-07, accession 0000883984-25-000030.Report this figure163Selling, general and administrative, Q3 FY2024, three months to 2024-09-30$162.7m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-11-06, accession 0000883984-25-000035.Report this figure159Selling, general and administrative, Q4 FY2024, three months to 2024-12-31$158.8m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-02-19, accession 0000883984-26-000008. Derived: 12-month figure less the 9-month figure.Report this figure157Selling, general and administrative, Q1 FY2025, three months to 2025-03-31$157.2m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-05-07, accession 0000883984-26-000029.Report this figure159Selling, general and administrative, Q2 FY2025, three months to 2025-06-30$159.4m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-08-06, accession 0000883984-26-000041.Report this figure153Selling, general and administrative, Q3 FY2025, three months to 2025-09-30$152.8m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-11-06, accession 0000883984-25-000035.Report this figure156Selling, general and administrative, Q4 FY2025, three months to 2025-12-31$155.8m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-02-19, accession 0000883984-26-000008. Derived: 12-month figure less the 9-month figure.Report this figure155Selling, general and administrative, Q1 FY2026, three months to 2026-03-31$154.6m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-05-07, accession 0000883984-26-000029.Report this figure152Selling, general and administrative, Q2 FY2026, three months to 2026-06-30$151.9m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-08-06, accession 0000883984-26-000041.Report this figure
Operating income$m22.9Operating income, Q3 FY2023, three months to 2023-09-30$22.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-12, accession 0000883984-24-000042.Report this figure(12.2)Operating income, Q4 FY2023, three months to 2023-12-31−$12.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-19, accession 0000883984-26-000008. Derived: 12-month figure less the 9-month figure.Report this figure(10.7)Operating income, Q1 FY2024, three months to 2024-03-31−$10.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-08, accession 0000883984-25-000016.Report this figure7.7Operating income, Q2 FY2024, three months to 2024-06-30$7.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-07, accession 0000883984-25-000030.Report this figure8.2Operating income, Q3 FY2024, three months to 2024-09-30$8.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-06, accession 0000883984-25-000035.Report this figure37.7Operating income, Q4 FY2024, three months to 2024-12-31$37.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-19, accession 0000883984-26-000008. Derived: 12-month figure less the 9-month figure.Report this figure12.9Operating income, Q1 FY2025, three months to 2025-03-31$12.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-07, accession 0000883984-26-000029.Report this figure10.6Operating income, Q2 FY2025, three months to 2025-06-30$10.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-06, accession 0000883984-26-000041.Report this figure13.7Operating income, Q3 FY2025, three months to 2025-09-30$13.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-06, accession 0000883984-25-000035.Report this figure5.6Operating income, Q4 FY2025, three months to 2025-12-31$5.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-19, accession 0000883984-26-000008. Derived: 12-month figure less the 9-month figure.Report this figure13.6Operating income, Q1 FY2026, three months to 2026-03-31$13.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-07, accession 0000883984-26-000029.Report this figure39.1Operating income, Q2 FY2026, three months to 2026-06-30$39.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-06, accession 0000883984-26-000041.Report this figure
Interest expense$m24.2Interest expense, Q3 FY2023, three months to 2023-09-30$24.2m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2024-11-12, accession 0000883984-24-000042.Report this figure31.9Interest expense, Q4 FY2023, three months to 2023-12-31$31.9m. XBRL concept us-gaap:InterestExpense. 10-K filed 2026-02-19, accession 0000883984-26-000008. Derived: 12-month figure less the 9-month figure.Report this figure23.8Interest expense, Q1 FY2024, three months to 2024-03-31$23.8m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2025-05-08, accession 0000883984-25-000016.Report this figure23.8Interest expense, Q2 FY2024, three months to 2024-06-30$23.8m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2025-08-07, accession 0000883984-25-000030.Report this figure24.7Interest expense, Q3 FY2024, three months to 2024-09-30$24.7m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2025-11-06, accession 0000883984-25-000035.Report this figure34.2Interest expense, Q4 FY2024, three months to 2024-12-31$34.2m. XBRL concept us-gaap:InterestExpense. 10-K filed 2026-02-19, accession 0000883984-26-000008. Derived: 12-month figure less the 9-month figure.Report this figure22.0Interest expense, Q1 FY2025, three months to 2025-03-31$22.0m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2026-05-07, accession 0000883984-26-000029.Report this figure20.5Interest expense, Q2 FY2025, three months to 2025-06-30$20.5m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2026-08-06, accession 0000883984-26-000041.Report this figure19.8Interest expense, Q3 FY2025, three months to 2025-09-30$19.8m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2025-11-06, accession 0000883984-25-000035.Report this figure31.0Interest expense, Q4 FY2025, three months to 2025-12-31$30.9m. XBRL concept us-gaap:InterestExpense. 10-K filed 2026-02-19, accession 0000883984-26-000008. Derived: 12-month figure less the 9-month figure.Report this figure16.5Interest expense, Q1 FY2026, three months to 2026-03-31$16.5m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2026-05-07, accession 0000883984-26-000029.Report this figure15.7Interest expense, Q2 FY2026, three months to 2026-06-30$15.7m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2026-08-06, accession 0000883984-26-000041.Report this figure
Income tax$m(12.6)Income tax, Q3 FY2023, three months to 2023-09-30−$12.6m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2024-11-12, accession 0000883984-24-000042.Report this figure(19.5)Income tax, Q4 FY2023, three months to 2023-12-31−$19.5m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-19, accession 0000883984-26-000008. Derived: 12-month figure less the 9-month figure.Report this figure2.7Income tax, Q1 FY2024, three months to 2024-03-31$2.7m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-05-08, accession 0000883984-25-000016.Report this figure1.9Income tax, Q2 FY2024, three months to 2024-06-30$1.9m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-08-07, accession 0000883984-25-000030.Report this figure15.1Income tax, Q3 FY2024, three months to 2024-09-30$15.1m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-06, accession 0000883984-25-000035.Report this figure32.0Income tax, Q4 FY2024, three months to 2024-12-31$32.0m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-19, accession 0000883984-26-000008. Derived: 12-month figure less the 9-month figure.Report this figure4.6Income tax, Q1 FY2025, three months to 2025-03-31$4.6m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-07, accession 0000883984-26-000029.Report this figure1.2Income tax, Q2 FY2025, three months to 2025-06-30$1.2m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-06, accession 0000883984-26-000041.Report this figure(0.7)Income tax, Q3 FY2025, three months to 2025-09-30−$658.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-06, accession 0000883984-25-000035.Report this figure(2.7)Income tax, Q4 FY2025, three months to 2025-12-31−$2.7m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-19, accession 0000883984-26-000008. Derived: 12-month figure less the 9-month figure.Report this figure(34.7)Income tax, Q1 FY2026, three months to 2026-03-31−$34.7m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-07, accession 0000883984-26-000029.Report this figure7.1Income tax, Q2 FY2026, three months to 2026-06-30$7.1m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-06, accession 0000883984-26-000041.Report this figure
Net income$m7.2Net income, Q3 FY2023, three months to 2023-09-30$7.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-12, accession 0000883984-24-000042.Report this figure(17.1)Net income, Q4 FY2023, three months to 2023-12-31−$17.1m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-19, accession 0000883984-26-000008. Derived: 12-month figure less the 9-month figure.Report this figure(39.5)Net income, Q1 FY2024, three months to 2024-03-31−$39.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-06, accession 0000883984-25-000035.Report this figure(21.4)Net income, Q2 FY2024, three months to 2024-06-30−$21.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-06, accession 0000883984-25-000035.Report this figure(33.0)Net income, Q3 FY2024, three months to 2024-09-30−$33.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-06, accession 0000883984-25-000035.Report this figure(23.8)Net income, Q4 FY2024, three months to 2024-12-31−$23.8m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-19, accession 0000883984-26-000008. Derived: 12-month figure less the 9-month figure.Report this figure(15.5)Net income, Q1 FY2025, three months to 2025-03-31−$15.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-06, accession 0000883984-26-000041.Report this figure35.3Net income, Q2 FY2025, three months to 2025-06-30$35.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-06, accession 0000883984-26-000041.Report this figure(3.4)Net income, Q3 FY2025, three months to 2025-09-30−$3.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-06, accession 0000883984-25-000035.Report this figure(15.7)Net income, Q4 FY2025, three months to 2025-12-31−$15.7m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-19, accession 0000883984-26-000008. Derived: 12-month figure less the 9-month figure.Report this figure30.1Net income, Q1 FY2026, three months to 2026-03-31$30.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-06, accession 0000883984-26-000041.Report this figure19.1Net income, Q2 FY2026, three months to 2026-06-30$19.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-06, accession 0000883984-26-000041.Report this figure
Diluted EPS$ per share0.30Diluted EPS, Q3 FY2023, three months to 2023-09-30$0.30 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-12, accession 0000883984-24-000042.Report this figurenot reported(1.63)Diluted EPS, Q1 FY2024, three months to 2024-03-31−$1.63 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-08, accession 0000883984-25-000016.Report this figure(0.88)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$0.88 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-07, accession 0000883984-25-000030.Report this figure(1.35)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$1.35 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-06, accession 0000883984-25-000035.Report this figurenot reported(0.63)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$0.63 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-07, accession 0000883984-26-000029.Report this figure1.43Diluted EPS, Q2 FY2025, three months to 2025-06-30$1.43 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-06, accession 0000883984-26-000041.Report this figure(0.14)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$0.14 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-06, accession 0000883984-25-000035.Report this figurenot reported1.20Diluted EPS, Q1 FY2026, three months to 2026-03-31$1.20 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-07, accession 0000883984-26-000029.Report this figure0.76Diluted EPS, Q2 FY2026, three months to 2026-06-30$0.76 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-06, accession 0000883984-26-000041.Report this figure
Basic EPS$ per share0.30Basic EPS, Q3 FY2023, three months to 2023-09-30$0.30 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-12, accession 0000883984-24-000042.Report this figurenot reported(1.63)Basic EPS, Q1 FY2024, three months to 2024-03-31−$1.63 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-08, accession 0000883984-25-000016.Report this figure(0.88)Basic EPS, Q2 FY2024, three months to 2024-06-30−$0.88 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-07, accession 0000883984-25-000030.Report this figure(1.35)Basic EPS, Q3 FY2024, three months to 2024-09-30−$1.35 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-06, accession 0000883984-25-000035.Report this figurenot reported(0.63)Basic EPS, Q1 FY2025, three months to 2025-03-31−$0.63 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-07, accession 0000883984-26-000029.Report this figure1.43Basic EPS, Q2 FY2025, three months to 2025-06-30$1.43 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-06, accession 0000883984-26-000041.Report this figure(0.14)Basic EPS, Q3 FY2025, three months to 2025-09-30−$0.14 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-06, accession 0000883984-25-000035.Report this figurenot reported1.22Basic EPS, Q1 FY2026, three months to 2026-03-31$1.22 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-07, accession 0000883984-26-000029.Report this figure0.76Basic EPS, Q2 FY2026, three months to 2026-06-30$0.76 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-06, accession 0000883984-26-000041.Report this figure

Balance sheet

Long-term debt$1.21bn, Q2 FY2026
Shareholders' equity$2.15bn, Q2 FY2026
ICU Medical Inc, balance sheet, quarterly
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Current assets$m1,219Current assets, Q3 FY2023, at 2023-09-30$1.22bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-06, accession 0000883984-23-000038.Report this figure1,221Current assets, FY2023, at 2023-12-31$1.22bn. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-02-27, accession 0000883984-25-000007.Report this figure1,188Current assets, Q1 FY2024, at 2024-03-31$1.19bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-07, accession 0000883984-24-000016.Report this figure1,236Current assets, Q2 FY2024, at 2024-06-30$1.24bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-07, accession 0000883984-24-000030.Report this figure1,258Current assets, Q3 FY2024, at 2024-09-30$1.26bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-12, accession 0000883984-24-000042.Report this figure1,442Current assets, FY2024, at 2024-12-31$1.44bn. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-02-19, accession 0000883984-26-000008.Report this figure1,424Current assets, Q1 FY2025, at 2025-03-31$1.42bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-08, accession 0000883984-25-000016.Report this figure1,180Current assets, Q2 FY2025, at 2025-06-30$1.18bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-07, accession 0000883984-25-000030.Report this figure1,207Current assets, Q3 FY2025, at 2025-09-30$1.21bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-06, accession 0000883984-25-000035.Report this figure1,191Current assets, FY2025, at 2025-12-31$1.19bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-06, accession 0000883984-26-000041.Report this figure1,213Current assets, Q1 FY2026, at 2026-03-31$1.21bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-07, accession 0000883984-26-000029.Report this figure1,211Current assets, Q2 FY2026, at 2026-06-30$1.21bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-06, accession 0000883984-26-000041.Report this figure
Total assets$m4,377Total assets, Q3 FY2023, at 2023-09-30$4.38bn. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-06, accession 0000883984-23-000038.Report this figure4,378Total assets, FY2023, at 2023-12-31$4.38bn. XBRL concept us-gaap:Assets. 10-K filed 2025-02-27, accession 0000883984-25-000007.Report this figure4,288Total assets, Q1 FY2024, at 2024-03-31$4.29bn. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-07, accession 0000883984-24-000016.Report this figure4,287Total assets, Q2 FY2024, at 2024-06-30$4.29bn. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-07, accession 0000883984-24-000030.Report this figure4,305Total assets, Q3 FY2024, at 2024-09-30$4.31bn. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-12, accession 0000883984-24-000042.Report this figure4,204Total assets, FY2024, at 2024-12-31$4.20bn. XBRL concept us-gaap:Assets. 10-K filed 2026-02-19, accession 0000883984-26-000008.Report this figure4,185Total assets, Q1 FY2025, at 2025-03-31$4.18bn. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-08, accession 0000883984-25-000016.Report this figure4,107Total assets, Q2 FY2025, at 2025-06-30$4.11bn. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-07, accession 0000883984-25-000030.Report this figure4,103Total assets, Q3 FY2025, at 2025-09-30$4.10bn. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-06, accession 0000883984-25-000035.Report this figure4,051Total assets, FY2025, at 2025-12-31$4.05bn. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-06, accession 0000883984-26-000041.Report this figure4,014Total assets, Q1 FY2026, at 2026-03-31$4.01bn. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-07, accession 0000883984-26-000029.Report this figure3,971Total assets, Q2 FY2026, at 2026-06-30$3.97bn. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-06, accession 0000883984-26-000041.Report this figure
Current liabilities$m464Current liabilities, Q3 FY2023, at 2023-09-30$464.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-06, accession 0000883984-23-000038.Report this figure482Current liabilities, FY2023, at 2023-12-31$481.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-02-27, accession 0000883984-25-000007.Report this figure455Current liabilities, Q1 FY2024, at 2024-03-31$455.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-07, accession 0000883984-24-000016.Report this figure512Current liabilities, Q2 FY2024, at 2024-06-30$511.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-07, accession 0000883984-24-000030.Report this figure550Current liabilities, Q3 FY2024, at 2024-09-30$549.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-12, accession 0000883984-24-000042.Report this figure556Current liabilities, FY2024, at 2024-12-31$556.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-02-19, accession 0000883984-26-000008.Report this figure549Current liabilities, Q1 FY2025, at 2025-03-31$549.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-08, accession 0000883984-25-000016.Report this figure483Current liabilities, Q2 FY2025, at 2025-06-30$482.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-07, accession 0000883984-25-000030.Report this figure493Current liabilities, Q3 FY2025, at 2025-09-30$492.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-06, accession 0000883984-25-000035.Report this figure499Current liabilities, FY2025, at 2025-12-31$498.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-06, accession 0000883984-26-000041.Report this figure518Current liabilities, Q1 FY2026, at 2026-03-31$517.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-07, accession 0000883984-26-000029.Report this figure498Current liabilities, Q2 FY2026, at 2026-06-30$498.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-06, accession 0000883984-26-000041.Report this figure
Long-term debt$m1,589Long-term debt, Q3 FY2023, at 2023-09-30$1.59bn. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2023-11-06, accession 0000883984-23-000038.Report this figure1,578Long-term debt, FY2023, at 2023-12-31$1.58bn. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-K filed 2025-02-27, accession 0000883984-25-000007.Report this figure1,566Long-term debt, Q1 FY2024, at 2024-03-31$1.57bn. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2024-05-07, accession 0000883984-24-000016.Report this figure1,555Long-term debt, Q2 FY2024, at 2024-06-30$1.55bn. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2024-08-07, accession 0000883984-24-000030.Report this figure1,543Long-term debt, Q3 FY2024, at 2024-09-30$1.54bn. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2024-11-12, accession 0000883984-24-000042.Report this figure1,532Long-term debt, FY2024, at 2024-12-31$1.53bn. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-K filed 2026-02-19, accession 0000883984-26-000008.Report this figure1,489Long-term debt, Q1 FY2025, at 2025-03-31$1.49bn. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2025-05-08, accession 0000883984-25-000016.Report this figure1,338Long-term debt, Q2 FY2025, at 2025-06-30$1.34bn. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2025-08-07, accession 0000883984-25-000030.Report this figure1,314Long-term debt, Q3 FY2025, at 2025-09-30$1.31bn. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2025-11-06, accession 0000883984-25-000035.Report this figure1,266Long-term debt, FY2025, at 2025-12-31$1.27bn. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2026-08-06, accession 0000883984-26-000041.Report this figure1,262Long-term debt, Q1 FY2026, at 2026-03-31$1.26bn. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2026-05-07, accession 0000883984-26-000029.Report this figure1,212Long-term debt, Q2 FY2026, at 2026-06-30$1.21bn. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2026-08-06, accession 0000883984-26-000041.Report this figure
Current portion of debt$m45.7Current portion of debt, Q3 FY2023, at 2023-09-30$45.7m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2023-11-06, accession 0000883984-23-000038.Report this figure51.0Current portion of debt, FY2023, at 2023-12-31$51.0m. XBRL concept us-gaap:LongTermDebtCurrent. 10-K filed 2025-02-27, accession 0000883984-25-000007.Report this figure51.0Current portion of debt, Q1 FY2024, at 2024-03-31$51.0m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2024-05-07, accession 0000883984-24-000016.Report this figure51.0Current portion of debt, Q2 FY2024, at 2024-06-30$51.0m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2024-08-07, accession 0000883984-24-000030.Report this figure51.0Current portion of debt, Q3 FY2024, at 2024-09-30$51.0m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2024-11-12, accession 0000883984-24-000042.Report this figure51.0Current portion of debt, FY2024, at 2024-12-31$51.0m. XBRL concept us-gaap:LongTermDebtCurrent. 10-K filed 2026-02-19, accession 0000883984-26-000008.Report this figure47.8Current portion of debt, Q1 FY2025, at 2025-03-31$47.8m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2025-05-08, accession 0000883984-25-000016.Report this figure0.0Current portion of debt, Q2 FY2025, at 2025-06-30$0. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2025-08-07, accession 0000883984-25-000030.Report this figure0.0Current portion of debt, Q3 FY2025, at 2025-09-30$0. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2025-11-06, accession 0000883984-25-000035.Report this figure18.8Current portion of debt, FY2025, at 2025-12-31$18.8m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2026-08-06, accession 0000883984-26-000041.Report this figure18.8Current portion of debt, Q1 FY2026, at 2026-03-31$18.8m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2026-05-07, accession 0000883984-26-000029.Report this figure18.8Current portion of debt, Q2 FY2026, at 2026-06-30$18.8m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2026-08-06, accession 0000883984-26-000041.Report this figure
Shareholders' equity$m2,098Shareholders' equity, Q3 FY2023, at 2023-09-30$2.10bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-12, accession 0000883984-24-000042.Report this figure2,123Shareholders' equity, FY2023, at 2023-12-31$2.12bn. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-02-19, accession 0000883984-26-000008.Report this figure2,068Shareholders' equity, Q1 FY2024, at 2024-03-31$2.07bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-06, accession 0000883984-25-000035.Report this figure2,038Shareholders' equity, Q2 FY2024, at 2024-06-30$2.04bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-06, accession 0000883984-25-000035.Report this figure2,049Shareholders' equity, Q3 FY2024, at 2024-09-30$2.05bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-06, accession 0000883984-25-000035.Report this figure1,965Shareholders' equity, FY2024, at 2024-12-31$1.97bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0000883984-26-000041.Report this figure1,988Shareholders' equity, Q1 FY2025, at 2025-03-31$1.99bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0000883984-26-000041.Report this figure2,116Shareholders' equity, Q2 FY2025, at 2025-06-30$2.12bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0000883984-26-000041.Report this figure2,127Shareholders' equity, Q3 FY2025, at 2025-09-30$2.13bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-06, accession 0000883984-25-000035.Report this figure2,124Shareholders' equity, FY2025, at 2025-12-31$2.12bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0000883984-26-000041.Report this figure2,112Shareholders' equity, Q1 FY2026, at 2026-03-31$2.11bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0000883984-26-000041.Report this figure2,152Shareholders' equity, Q2 FY2026, at 2026-06-30$2.15bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0000883984-26-000041.Report this figure

Cash flow

Operating cash flow$80.2m, Q2 FY2026
Capital expenditure$18.5m, Q2 FY2026
ICU Medical Inc, cash flow, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m35.2Operating cash flow, Q3 FY2023, three months to 2023-09-30$35.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-12, accession 0000883984-24-000042. Derived: 9-month figure less the 6-month figure.Report this figure91.3Operating cash flow, Q4 FY2023, three months to 2023-12-31$91.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-19, accession 0000883984-26-000008. Derived: 12-month figure less the 9-month figure.Report this figure45.8Operating cash flow, Q1 FY2024, three months to 2024-03-31$45.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-08, accession 0000883984-25-000016.Report this figure82.0Operating cash flow, Q2 FY2024, three months to 2024-06-30$82.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-07, accession 0000883984-25-000030. Derived: 6-month figure less the 3-month figure.Report this figure36.1Operating cash flow, Q3 FY2024, three months to 2024-09-30$36.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-06, accession 0000883984-25-000035. Derived: 9-month figure less the 6-month figure.Report this figure40.2Operating cash flow, Q4 FY2024, three months to 2024-12-31$40.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-19, accession 0000883984-26-000008. Derived: 12-month figure less the 9-month figure.Report this figure51.3Operating cash flow, Q1 FY2025, three months to 2025-03-31$51.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-07, accession 0000883984-26-000029.Report this figure11.2Operating cash flow, Q2 FY2025, three months to 2025-06-30$11.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-06, accession 0000883984-26-000041. Derived: 6-month figure less the 3-month figure.Report this figure56.7Operating cash flow, Q3 FY2025, three months to 2025-09-30$56.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-06, accession 0000883984-25-000035. Derived: 9-month figure less the 6-month figure.Report this figure60.6Operating cash flow, Q4 FY2025, three months to 2025-12-31$60.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-19, accession 0000883984-26-000008. Derived: 12-month figure less the 9-month figure.Report this figure38.9Operating cash flow, Q1 FY2026, three months to 2026-03-31$38.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-07, accession 0000883984-26-000029.Report this figure80.2Operating cash flow, Q2 FY2026, three months to 2026-06-30$80.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-06, accession 0000883984-26-000041. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$m21.5Capital expenditure, Q3 FY2023, three months to 2023-09-30$21.5m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-11-12, accession 0000883984-24-000042. Derived: 9-month figure less the 6-month figure.Report this figure29.9Capital expenditure, Q4 FY2023, three months to 2023-12-31$29.9m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-19, accession 0000883984-26-000008. Derived: 12-month figure less the 9-month figure.Report this figure15.9Capital expenditure, Q1 FY2024, three months to 2024-03-31$15.9m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-05-08, accession 0000883984-25-000016.Report this figure19.5Capital expenditure, Q2 FY2024, three months to 2024-06-30$19.5m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-08-07, accession 0000883984-25-000030. Derived: 6-month figure less the 3-month figure.Report this figure19.9Capital expenditure, Q3 FY2024, three months to 2024-09-30$19.9m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-06, accession 0000883984-25-000035. Derived: 9-month figure less the 6-month figure.Report this figure24.1Capital expenditure, Q4 FY2024, three months to 2024-12-31$24.1m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-19, accession 0000883984-26-000008. Derived: 12-month figure less the 9-month figure.Report this figure14.6Capital expenditure, Q1 FY2025, three months to 2025-03-31$14.6m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-07, accession 0000883984-26-000029.Report this figure19.7Capital expenditure, Q2 FY2025, three months to 2025-06-30$19.7m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-06, accession 0000883984-26-000041. Derived: 6-month figure less the 3-month figure.Report this figure29.1Capital expenditure, Q3 FY2025, three months to 2025-09-30$29.1m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-06, accession 0000883984-25-000035. Derived: 9-month figure less the 6-month figure.Report this figure24.6Capital expenditure, Q4 FY2025, three months to 2025-12-31$24.6m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-19, accession 0000883984-26-000008. Derived: 12-month figure less the 9-month figure.Report this figure11.3Capital expenditure, Q1 FY2026, three months to 2026-03-31$11.3m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-07, accession 0000883984-26-000029.Report this figure18.5Capital expenditure, Q2 FY2026, three months to 2026-06-30$18.5m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-06, accession 0000883984-26-000041. Derived: 6-month figure less the 3-month figure.Report this figure
Share repurchases$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported

Shares

Diluted shares (weighted)25.04m, Q2 FY2026
ICU Medical Inc, shares, quarterly
Line itemUnitQ3 FY20222022-09-30Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares23.9Diluted shares (weighted), Q3 FY2022, three months to 2022-09-3023,908,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-06, accession 0000883984-23-000038.Report this figure24.0Diluted shares (weighted), Q1 FY2023, three months to 2023-03-3124,014,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-07, accession 0000883984-24-000016.Report this figure24.1Diluted shares (weighted), Q2 FY2023, three months to 2023-06-3024,075,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-07, accession 0000883984-24-000030.Report this figure24.4Diluted shares (weighted), Q3 FY2023, three months to 2023-09-3024,368,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-12, accession 0000883984-24-000042.Report this figure24.2Diluted shares (weighted), Q1 FY2024, three months to 2024-03-3124,222,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-08, accession 0000883984-25-000016.Report this figure24.4Diluted shares (weighted), Q2 FY2024, three months to 2024-06-3024,393,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-07, accession 0000883984-25-000030.Report this figure24.4Diluted shares (weighted), Q3 FY2024, three months to 2024-09-3024,438,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-06, accession 0000883984-25-000035.Report this figure24.5Diluted shares (weighted), Q1 FY2025, three months to 2025-03-3124,539,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-07, accession 0000883984-26-000029.Report this figure24.7Diluted shares (weighted), Q2 FY2025, three months to 2025-06-3024,708,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-06, accession 0000883984-26-000041.Report this figure24.7Diluted shares (weighted), Q3 FY2025, three months to 2025-09-3024,686,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-06, accession 0000883984-25-000035.Report this figure25.2Diluted shares (weighted), Q1 FY2026, three months to 2026-03-3125,182,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-07, accession 0000883984-26-000029.Report this figure25.0Diluted shares (weighted), Q2 FY2026, three months to 2026-06-3025,044,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-06, accession 0000883984-26-000041.Report this figure

Shares outstanding: 25.01mShares outstanding, period not labelled, at 2026-07-3125,007,038 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-06, accession 0000883984-26-000041.Report this figure at Jul 31, 2026, from the cover of the 10-Q filed Aug 6, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:27 ET. Listed shows no prices and gives no investment advice.